poisar

Stock

Biofrontera Inc. BFRI

$0.98+3.82%

Overview

BFRI market data

Price History

BFRI price chart

Valuation & Profitability

no valuation data
No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for BFRI. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

8 captured
Photodynamic Therapy Market: Durable Growth with a CAGR of 8.3% Through 2035Globenewswire Inc · Jul 3, 2026, 12:15 PM
This Hanover Insurance Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For TuesdayBenzinga · May 19, 2026, 2:35 PM
This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For TuesdayBenzinga · May 19, 2026, 2:35 PM
Benchmark Downgrades Biofrontera to Speculative Buy, Maintains Price Target to $3Benzinga · May 19, 2026, 12:45 PM
Transcript: Biofrontera Q1 2026 Earnings Conference CallBenzinga · May 14, 2026, 3:39 PM
Biofrontera Q1 EPS $(0.41) Misses $(0.12) Estimate, Sales $10.084M Miss $10.250M EstimateBenzinga · May 14, 2026, 12:08 PM
Earnings Scheduled For May 14, 2026Benzinga · May 14, 2026, 11:11 AM
Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026Globenewswire Inc · May 8, 2026, 8:05 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock